genedrive plc (LON:GDR – Get Free Report)’s share price fell 11.2% on Monday . The company traded as low as GBX 0.50 ($0.01) and last traded at GBX 0.53 ($0.01). 9,043,583 shares changed hands during mid-day trading, a decline of 52% from the average session volume of 18,940,135 shares. The stock had previously closed at GBX 0.60 ($0.01).
genedrive Stock Performance
The business’s 50-day simple moving average is GBX 0.53 and its two-hundred day simple moving average is GBX 1.11. The firm has a market cap of £5.33 million, a price-to-earnings ratio of -0.24 and a beta of -0.04. The company has a quick ratio of 5.52, a current ratio of 4.60 and a debt-to-equity ratio of 0.35.
genedrive Company Profile
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
Read More
- Five stocks we like better than genedrive
- What Does a Stock Split Mean?
- JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?
- Consumer Staples Stocks, Explained
- Snap-on Incorporated: Snap It Up Quick, New Highs Will Come Soon
- How to Calculate Return on Investment (ROI)
- As Global Renewables Surpass Coal, This ETF Offers Smart Exposure
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.